You are here

Justice News

Department of Justice
U.S. Attorney’s Office
District of Kansas

FOR IMMEDIATE RELEASE
Tuesday, May 30, 2017

Texas Woman Sentenced In Designer Drug Case in Kansas

TOPEKA, KAN. - A Texas woman was sentenced Tuesday to five years in federal prison for selling designer drugs manufactured in Kansas, U.S. Attorney Tom Beall said. She was ordered to forfeit $2 million in proceeds from the crime.

 

Michelle Reulet, 37, Montgomery, Texas, pleaded guilty to one count of conspiracy to commit mail fraud. Reulet and co-defendant Michael Myers owned a business in the Houston area called Bully Wholesale. They sold products that were purchased from co-defendants Tracy Picanso and Roy Ehrett in Olathe, Kan.

 

The products Reulet’s company sold designer drugs marketed under names such as Pump It, Head trip, Black Arts and Grave Digger. In her plea, Reulet admitted she knew buyers consumed her products to get high, despite labels making false claims that the products were safe and were not intended for human consumption. The products were marketed as incense, potpourri and shoe deodorizer. Their labels did not warn of possible harmful effects.

 

Reulet’s business had gross sales of more than $2 million.

 

Co-defendants include:

Tracy Picanso, 61, Olathe, Kan., who is set for sentencing June 15.

Roy Ehrett, 59, Olathe, Kan., who is set for sentencing June 15.

Michael Myers, 37, Montgomery, Texas, who was sentenced to time served (two years).

 

Beall commended the Drug Enforcement Administration, the Food and Drug Administration – Office of Criminal Investigations, the Department of Homeland Security, Homeland Security Investigations, Customs and Border Protection, the FBI, the Overland Park Police Department, the Johnson County Sheriff’s Office, the Olathe Police Department, the St. Joseph Police Department and the Buchanan County Drug Strike Force, Assistant U.S. Attorney Tanya Treadway and Michael Varrone, Associate Chief Counsel, Food and Drug Administration, for their work on the case.

Topic(s): 
Drug Trafficking
Component(s): 
Updated May 30, 2017